NL162647C - Werkwijze ter bereiding van anti-inflammatoir werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, en werkwijze ter bereiding van anti-inflammatoir werkzame fenylazijn- zuurderivaten. - Google Patents

Werkwijze ter bereiding van anti-inflammatoir werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, en werkwijze ter bereiding van anti-inflammatoir werkzame fenylazijn- zuurderivaten.

Info

Publication number
NL162647C
NL162647C NL6903273.A NL6903273A NL162647C NL 162647 C NL162647 C NL 162647C NL 6903273 A NL6903273 A NL 6903273A NL 162647 C NL162647 C NL 162647C
Authority
NL
Netherlands
Prior art keywords
inflammatic
preparation
phenylatives
activated
pharmaceutical preparations
Prior art date
Application number
NL6903273.A
Other languages
English (en)
Other versions
NL6903273A (nl
NL162647B (nl
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NL6903273A publication Critical patent/NL6903273A/xx
Publication of NL162647B publication Critical patent/NL162647B/nl
Application granted granted Critical
Publication of NL162647C publication Critical patent/NL162647C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
NL6903273.A 1968-03-27 1969-03-03 Werkwijze ter bereiding van anti-inflammatoir werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, en werkwijze ter bereiding van anti-inflammatoir werkzame fenylazijn- zuurderivaten. NL162647C (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71634768A 1968-03-27 1968-03-27
US75713668A 1968-09-03 1968-09-03
US79086369A 1969-01-13 1969-01-13

Publications (3)

Publication Number Publication Date
NL6903273A NL6903273A (nl) 1969-09-30
NL162647B NL162647B (nl) 1980-01-15
NL162647C true NL162647C (nl) 1980-06-16

Family

ID=27418953

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6903273.A NL162647C (nl) 1968-03-27 1969-03-03 Werkwijze ter bereiding van anti-inflammatoir werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, en werkwijze ter bereiding van anti-inflammatoir werkzame fenylazijn- zuurderivaten.

Country Status (26)

Country Link
JP (1) JPS5330712B1 (nl)
AR (7) AR192699A1 (nl)
AT (8) AT291242B (nl)
BE (1) BE730520A (nl)
BG (3) BG20567A3 (nl)
CH (11) CH563984A5 (nl)
CS (8) CS153506B2 (nl)
CY (1) CY809A (nl)
DE (1) DE1913743A1 (nl)
DK (1) DK145226C (nl)
FI (1) FI52579C (nl)
FR (1) FR2004827A1 (nl)
GB (1) GB1268831A (nl)
IE (1) IE33153B1 (nl)
IL (1) IL31861A (nl)
KE (1) KE2542A (nl)
MY (1) MY7500152A (nl)
NL (1) NL162647C (nl)
NO (1) NO132199C (nl)
OA (1) OA03609A (nl)
PH (1) PH12640A (nl)
PL (1) PL74820B1 (nl)
RO (4) RO66273A (nl)
SE (1) SE382812B (nl)
SU (4) SU419029A3 (nl)
YU (3) YU39653B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2025518A1 (nl) * 1969-06-05 1970-12-10
DE2013376A1 (de) * 1970-03-20 1971-10-07 Merck Patent Gmbh Substituierte Phenylessigsauren und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
IE33153B1 (en) 1974-04-03
DK145226C (da) 1983-03-28
AT291239B (de) 1971-07-12
RO64901A (fr) 1979-08-15
AR193194A1 (es) 1973-04-11
CH559755A5 (nl) 1975-03-14
AT291241B (de) 1971-07-12
BE730520A (nl) 1969-09-26
CH563985A5 (nl) 1975-07-15
NO132199C (nl) 1975-10-08
YU200074A (en) 1982-06-30
SE382812B (sv) 1976-02-16
DE1913743A1 (de) 1969-11-20
SU459886A3 (ru) 1975-02-05
CH566990A5 (nl) 1975-09-30
FI52579C (fi) 1977-10-10
SU421191A3 (ru) 1974-03-25
NL6903273A (nl) 1969-09-30
CS153502B2 (nl) 1974-02-25
CS153510B2 (nl) 1974-02-25
YU200174A (en) 1982-06-30
FR2004827A1 (nl) 1969-12-05
YU39926B (en) 1985-06-30
CS153504B2 (nl) 1974-02-25
CH563984A5 (nl) 1975-07-15
AR193025A1 (es) 1973-03-30
NO132199B (nl) 1975-06-23
AR192699A1 (es) 1973-03-14
AR193024A1 (es) 1973-03-30
PH12640A (en) 1979-07-05
YU149975A (en) 1982-06-30
CH563988A5 (nl) 1975-07-15
CH566991A5 (nl) 1975-09-30
YU39653B (en) 1985-03-20
BG20340A3 (bg) 1975-11-05
AT291237B (de) 1971-07-12
PL74820B1 (nl) 1974-12-31
GB1268831A (en) 1972-03-29
YU39532B (en) 1984-12-31
JPS5330712B1 (nl) 1978-08-29
CS153508B2 (nl) 1974-02-25
SU428600A3 (ru) 1974-05-15
AT291234B (de) 1971-07-12
NL162647B (nl) 1980-01-15
CS153503B2 (nl) 1974-02-25
IL31861A (en) 1974-03-14
KE2542A (en) 1975-07-25
AR192864A1 (es) 1973-03-21
MY7500152A (en) 1975-12-31
RO66269A (fr) 1979-03-15
RO66273A (ro) 1981-08-17
CS153505B2 (nl) 1974-02-25
CS153506B2 (nl) 1974-02-25
AR194569A1 (es) 1973-07-31
OA03609A (fr) 1971-03-30
AR192560A1 (es) 1973-02-28
CS153511B2 (nl) 1974-02-25
IE33153L (en) 1969-09-27
IL31861A0 (en) 1969-05-28
SU419029A3 (ru) 1974-03-05
CH554859A (de) 1974-10-15
CH563381A5 (nl) 1975-06-30
FI52579B (nl) 1977-06-30
CH563986A5 (nl) 1975-07-15
AT291242B (de) 1971-07-12
AT287685B (de) 1971-02-10
CH563989A5 (nl) 1975-07-15
CH563983A5 (nl) 1975-07-15
AT291235B (de) 1971-07-12
BG20339A3 (bg) 1975-11-05
BG20567A3 (bg) 1975-12-05
AT291240B (de) 1971-07-12
DK145226B (da) 1982-10-11
CY809A (en) 1976-12-01
RO61382A (nl) 1976-10-15

Similar Documents

Publication Publication Date Title
NL7706646A (nl) Werkwijze ter bereiding van diuretisch werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, als- mede werkwijze ter bereiding van diuretisch werk- zame verbindingen.
NL162398B (nl) Werkwijze voor de bereiding van een entcopolymeer en gevormd voortbrengsel.
NL161759C (nl) Werkwijze ter bereiding van salicylzuurverbindingen, werkwijze ter bereiding van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
NL179287B (nl) Werkwijze voor het bereiden van steroiden van de pregnaanreeks, werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel.
NL161434C (nl) Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten.
NL144604B (nl) Werkwijze voor het bereiden van analgetisch werkzame benzazocineverbindingen, werkwijze voor het bereiden van analgetisch werkzame preparaten en gevormd geneesmiddel.
NL158386B (nl) Werkwijze ter bereiding van farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van farmacologisch werkzame 1h-1,5-benzodiazepine-2,4-dionderivaten.
NL152554B (nl) Werkwijze ter bereiding van farmacologisch werkzame preparaten en veevoer, gevormde voortbrengselen en bereiding van daartoe bruikbare stoffen.
NL164275C (nl) Werkwijze voor de bereiding van analgetisch werkzame hexahydro-1h-azepinederivaten, werkwijze ter bereiding van farmaceutische preparaten op basis van hexahydro- -1h-azepinederivaten en de onder toepassing daarvan verkregen gevormde farmaceutische preparaten.
NL172446C (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
NL166267C (nl) Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking.
NL162647C (nl) Werkwijze ter bereiding van anti-inflammatoir werkzame farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, en werkwijze ter bereiding van anti-inflammatoir werkzame fenylazijn- zuurderivaten.
NL170852C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van anti-inflammatoir werkzaam p-isoindolinylfenylazijnzuur en van derivaten hiervan.
NL159109B (nl) Werkwijze ter bereiding van cytostatisch werkzame derivaten van gefluoreerde pyrimidinenucleosiden, werkwijze ter bereiding van farmaceutische preparaten met cytostatische werking, alsmede de gevormde farmaceutische preparaten.
NL158783B (nl) Werkwijze voor het bereiden van farmaceutische preparaten met antifibrinolytische werking, door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van antifibrinolytisch werkzame aminozuren.
NL169871C (nl) Werkwijze voor de bereiding van p-nitrosofenolen en p-nitrofenolen.
NL175382C (nl) Werkwijze ter bereiding van antiflogistisch, analgetisch of antipyretisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van voor gebruik bij die werkwijze geschikte o-anilinofenylaceetamidederivaten.
NL175063C (nl) Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL156752B (nl) Werkwijze ter bereiding van een antibioticum, alsmede werkwijze ter bereiding van farmaceutische preparaten, alsmede door toepassing van deze werkwijze verkregen gevormde preparaten.
NL143933B (nl) Werkwijze voor de bereiding van anti-bacteriele stoffen en preparaten.
NL149372B (nl) Werkwijze voor het bereiden van farmaceutische preparaten, alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
NL163772C (nl) Werkwijze voor het bereiden van hypocalcemisch werkzame peptiden, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
NL142416B (nl) Werkwijze voor het bereiden van 6-amino-acylaminopenicillanzuren, alsmede werkwijze voor de bereiding van farmaceutische preparaten.
NL156320B (nl) Werkwijze voor de bereiding van benzylpenicillinederivaten, werkwijze ter bereiding van farmaceutische preparaten, alsmede de aldus verkregen gevormde voortbrengselen.
NL7504890A (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van nieuwe azamorfinanderivaten.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent